On Friday, the U.S. Judicial Panel on Multidistrict Litigation ordered nearly 70 lawsuits be coordinated beefore U.S.
Shareholders of Pfizer may learn more about this investigation by contacting Berger Montague: Radha Raghavan at [email protected] or (332) 271-8908, or Andrew Abramowitz at [email protected] or (215) ...
Newsworthy Women on MSN3mon
Depo-Provera Lawsuits Allege Pfizer Likely Knew it Caused Brain TumorsThe following content has been reviewed by a licensed attorney. Depo-Provera, a widely used injectable contraceptive, has ...
The Depo-Provera shot can be a convenient, lower-maintenance birth control option. You receive it in a doctor’s office every 3 months to help prevent pregnancy. Depo-Provera, commonly referred ...
Lawsuits allege that the defendants manufactured, promoted, and sold the prescription drug Depo-Provera without adequately warning of its connecti ...
Hosted on MSN1mon
Pfizer’s Depo-Provera contraceptive under fire: Study links it to brain tumor riskA new study published in the British Medical Journal (BMJ) has identified a link between the contraceptive injection Depo-Provera, manufactured by Pfizer, and an increased risk of meningiomas ...
A March 2024 study published in the British Medical Journal cemented a positive correlation between medroxyprogesterone acetate (MPA), the synthetic hormone found in Depo-Provera, and the tumors.
Medroxyprogesterone acetate 150mg/mL; IM inj. Medroxyprogesterone acetate inhibits the secretion of gonadotropins which primarily prevents follicular maturation and ovulation and causes thickening ...
The study published by Kenyan and Canadian scientists last Thursday says there is compelling evidence that Depo Provera increases the risk of HIV infections among users. In August 2019 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results